Trial NCT04476797

View at ClinicalTrials.gov 
Org. Study IDs: GTI-4711-101

Last trial update was posted on 2024-04-03

MeSH Interventions

Manganese

MeSH Conditions

Carcinoma, Non-Small-Cell Lung

Other Conditions

NSCLC Non-metastatic SBRT

Stopping Reasons

Development GC4711 was halted after the lead study in pancreatic cancer was stopped early due to meeting the requirements of a futility analysis

Limitations And Caveats

Study was terminated early by the Sponsor based on a the results of a futility analysis that was conducted on another program and the Sponsor decided to terminate the develop of GC4711. The last randomized subject did not complete protocol therapy but was followed for safety for a period of 30 days post the last administration of GC4711/Placebo +SBRT.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID